Takeda Pharmaceutical Co Ltd ADR

Yahoo Finance • 3 days ago

Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026

CEO Christophe Weber to retire from Takeda in June 2026 after 12 years Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession process OSAKA, Japan & CAMBRIDGE, Mass., January 30, 2025--(BUSINESS... Full story

Yahoo Finance • 4 days ago

Héma-Québec to Reimburse HyQvia® for the Treatment of Immunodeficiencies in Adult and Pediatric Patients Over 2 Years of Age

TORONTO, Jan. 29, 2025 /CNW/ - Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®– (normal immunoglobulin [human] 10% and recombinant human hyaluronidase solution for subcutaneous infusion) as a replaceme... Full story

Yahoo Finance • 5 days ago

Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights

Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights On Monday, Neurocrine Biosciences, Inc. (NASDAQ:NBIX) amended its agreement with Takeda Pharmaceutical Co Ltd (NYSE:TAK) to develop and commercialize... Full story

Yahoo Finance • last month

Japanese Stocks Are in the Spotlight Again. Hopes Are High for 2025.

Investors’ enthusiasm in early 2024 turned out to be misplaced, but corporate shake-ups, hints of inflation, and even trade issues could help the market now. Continue reading View comments... Full story

Yahoo Finance • 4 months ago

Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside

Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside HC Wainwright has initiated coverage on Alumis Inc. (NASDAQ:ALMS), a clinical-stage biopharmaceutical... Full story

Yahoo Finance • 5 months ago

Vatroslav Mateljic Appointed General Manager of Takeda Canada

Vatroslav Mateljic's innovative approach and commitment to transforming the lives of patients will strengthen Takeda's leadership position in the Canadian biopharmaceutical sector TORONTO, Sept. 16, 2024 /CNW/ - Takeda Canada Inc. ("Taked... Full story

Yahoo Finance • 8 months ago

Takeda Announces Partnership Expansion with Partners In Health to Extend Community-Centered Health Equity Initiative Across Massachusetts

The New Expanded Partnership Will Aim to Support the Dismantling of Systemic Barriers to Equity and Help Strengthen the Health Workforce in Massachusetts The Existing Global Partnership Has Provided Screening and Diagnostic Services to Ove... Full story

Yahoo Finance • 8 months ago

Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

cTTP Is an Ultra-rare, Potentially Fatal Blood-Clotting Disorder with Limited Treatment Options; Untreated, Acute TTP Events Have a Mortality Rate of >90%1,2 If Approved in the European Union, rADAMTS13 Will Be the First and Only Recombin... Full story

Yahoo Finance • 11 months ago

Japan's Takeda partners with India's Biological E. to boost dengue vaccine production

BENGALURU (Reuters) - Japan's Takeda Pharmaceutical will scale up production of its dengue vaccine Qdenga through a partnership with Indian vaccines maker Biological E., the companies said on Tuesday. These doses will be available for gov... Full story

Yahoo Finance • 11 months ago

11 Best Japanese Stocks To Buy In 2024

In this article, we discuss 11 best Japanese stocks to buy in 2024. If you want to skip our discussion on the Japanese economy, head over to 5 Best Japanese Stocks To Buy In 2024. Japan has effectively managed the challenges posed by the... Full story

Yahoo Finance • 11 months ago

20 Fastest Growing Biotech Companies in the US

In this article, we will be taking a look at the 20 fastest growing biotech companies in the US. If you are not interested in learning about the landscape of biotech companies, head straight to the 5 Fastest Growing Biotech Companies In Th... Full story

Yahoo Finance • 12 months ago

30 Most Valuable Drug Companies in 2024

In this article, we will take a look at the 30 most valuable drug companies in 2024. If you want to skip our detailed analysis of the pharmaceutical drugs market, you can go directly to 5 Most Valuable Drug Companies in 2024. The Global P... Full story

Yahoo Finance • 12 months ago

Takeda Intends to Rapidly Initiate the First Global Phase 3 Trials of TAK-861, an Oral Orexin Agonist, in Narcolepsy Type 1 in First Half of Fiscal Year 2024

− Primary and Key Secondary Endpoints Were Met in Narcolepsy Type 1 Phase 2b Trial − TAK-861 Was Found to be Generally Safe and Well-Tolerated − Results Will be Presented at an Upcoming Scientific Congress OSAKA, Japan & CAMBRIDGE, Mass... Full story

Yahoo Finance • last year

Takeda Announces Chief Financial Officer Succession

OSAKA, Japan & CAMBRIDGE, Mass., February 01, 2024--(BUSINESS WIRE)--Takeda (TOKYO:4502/NYSE:TAK) today announced that Costa Saroukos, chief financial officer, has decided to leave Takeda to return to his home-country of Australia to be cl... Full story

Yahoo Finance • last year

Takeda Pharmaceutical’s Third-Quarter Net Profit Dropped on Lower Margins

The Japanese drugmaker reported a drop in third-quarter net profit due partly to lower margins despite some growth in revenue. Continue reading... Full story

Yahoo Finance • last year

Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset

Takeda Will Be Protagonist's Co-Development, U.S. Co-Commercialization Partner With 50:50 Profit Share, and With Exclusive Ex-U.S. Global Rights to Commercialize Rusfertide, Protagonist's InvestigationalInjectable Hepcidin Mimetic Currentl... Full story

Yahoo Finance • last year

Takeda and The New York Academy of Sciences Announce 2024 Innovators in Science Award Winners

2024 Award Celebrates Outstanding Research in Cancer Immunology Winners Discovered Novel Connections Between the Immune System and Cancer Recipients Each Receive Unrestricted USD 200,000 Awards OSAKA, Japan & CAMBRIDGE, Mass., December 05... Full story

Yahoo Finance • last year

Hong Kong Shares Fall as Alibaba Slides

Hong Kong equities were lower in early trading, dragged by tepid sentiment in U.S. markets and a selloff in Alibaba. Continue reading... Full story

Yahoo Finance • last year

Takeda Pharmaceutical Books Second-Quarter Net Loss

Takeda Pharmaceutical reported a second-quarter net loss due to impairment losses on certain products and cut its net-profit forecast for the fiscal year ending March 2024. Continue reading... Full story

Yahoo Finance • last year

HUTCHMED Announces Submission of New Drug Application for Fruquintinib for Previously Treated Metastatic Colorectal Cancer in Japan

HUTCHMED (China) Limited — Third major market authorization application based on data from the FRESCO-2 global Phase III trial — HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Li... Full story